Connection
Laura Szczesniak to Narcotic Antagonists
This is a "connection" page, showing publications Laura Szczesniak has written about Narcotic Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.023 |
|
|
|
-
Szczesniak LM, Calleo VJ, Sullivan RW. Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report. Harm Reduct J. 2020 10 07; 17(1):71.
Score: 0.614
-
Szczesniak L, Britton S, Rn TB, Sullivan R. Low-dose overlap initiation with split tablets of buprenorphine in intubated intensive care unit patients with opioid use disorder. Harm Reduct J. 2024 06 07; 21(1):114.
Score: 0.198
-
Szczesniak L, Sullivan R. Microdose Induction of Buprenorphine in a Patient Using Tianeptine. J Addict Med. 2022 Nov-Dec 01; 16(6):736-738.
Score: 0.172
-
Sullivan RW, Szczesniak LM, Wojcik SM. Bridge clinic buprenorphine program decreases emergency department visits. J Subst Abuse Treat. 2021 11; 130:108410.
Score: 0.040